t(8;21) (q22;q22) Acute myelogenous leukemia in México: A single institution experience

Hematology

Volumn 11, Issue 4, 2006, Pages 235-238

  Ruiz Argüelles, Guillermo J ^a,b   Morales Toquero, Amelia ^a   Manzano, Carlos ^a   Ruiz Delgado, Guillermo J ^b   Jaramillo, Patricia ^c   Gonzalez Carrillo, Martha L ^b   Reyes Núñez, Virginia ^c  

^a CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

^c Hospital Medica Sur   (Mexico)

Author keywords

AML1 ETO; Leukemia; M xico; Myeloblastic; t(8; 21)

Indexed keywords

CYTARABINE; DOXORUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLAST CELL; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CAUCASIAN; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL FEATURE; DISEASE FREE SURVIVAL; DRUG MEGADOSE; EXPERIENCE; FEMALE; HUMAN; LEUKEMIA REMISSION; MALE; MEXICO; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; SCHOOL CHILD;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; COMBINED MODALITY THERAPY; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CYTARABINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; INFANT; KAPLAN-MEIERS ESTIMATE; LEUKEMIA, MYELOID; MALE; MEXICO; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREVALENCE; PROSPECTIVE STUDIES; REMISSION INDUCTION; SALVAGE THERAPY; TRANSLOCATION, GENETIC; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33845715785     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600702893     Document Type: Article

References (25)

1. Peterson, LF and Zhang, DE. (2004) The 8;21 translocation in leukemogenesis Oncogene, 23(24), pp. 4255-4262.
2. Ruiz-Argüelles, GJ and McArthur, J. (2003) Leucemias agudas. In Editorial Médica Panamericana 3rd ed. (pp. 180-197). México City
3. Visani, G and Isidori, A and Grafone, T and Tosi, P and Santini, V and Malagola, M and Martinelli, G and Piccaluga, PP and Gaziev, D and Ottaviani, E and Sparaventi, G and Tura, S. (2004) No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: Is intensity of therapy or high dose Ara-C crucial for response? Leukemia Lymphoma, 45, pp. 1361-1364.
4. Lai, YY and Qiu, JY and Jiang, B and Lu, XJ and Huang, XJ and Liu, YR and Shi, Y and Dang, H and He, Q and Lu, DP. (2005) Analysis of characteristics of 72 cases of t(8;21) acute myeloid leukemia Beijing Da Xue Xue Bao, 37, pp. 245-248.
5. Ruiz-Argüelles, A. (1992) Flow cytometry in the clinical laboratory. Principles, applications and problems Ann Biol Clin, 50, pp. 735-743.
6. San-Miguel, JF and Duque, R. (1996) Utilidad del inmunofenotipo en el diagnóstico y clasificación de las leucemias agudas. In Editorial Médica Panamericana. (pp. 25-34). Actualización en leucemias
7. Kozu, T and Miyoshi, H and Shimizu, K and Maseki, N and Kaneko, Y and Asou, H and Kamada, N and Ohki, M. (1993) Junctions of the AML1/MTG8 (ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction Blood, 82, pp. 1270-1276.
8. Ruiz-Argüelles, GJ and Garcés-Eisele, J and Reyes-Nûñez, V and Pérez-Romano, B and Ruiz-Argüelles, A and Ramírez-Cisneros, F and López-Martínez, B and López-Tapia, JD and Rivadeneyra-Espinoza, L. (2000) Assessment of residual disease in acute leukemia by means of polymerase chain reaction: A prospective study in a single institution Rev Invest Clin Méx, 52, pp. 118-124.
9. Ruiz-Argüelles, GJ and Apreza-Molina, MG and Alemán-Hoey, DD and Gómez-Almaguer, D and Marín-López, A and Mercado-Díaz, L. (1995) Outpatient supportive therapy after induction to remission therapy in adult acute myelogenous leukaemia (AML) is feasible: A multicentre study Eur J Haematol, 54, pp. 18-20.
10. Ruiz-Argüelles, GJ and Gómez-Rangel, D and Ruiz-Delgado, GJ and Ruiz-Argüelles, A and Pérez-Romano, B and Rivadeneyra, L. (2003) Results of an autologous non-cryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: A single institution, 10-year experience Acta Haematologica, 110, pp. 179-183.
11. Ruiz-Argüelles, GJ and Gómez-Almaguer, D and Gómez Rangel, JD and Vela-Ojeda, J and Cantú-Rodríguez, OG and Jaime-Pérez, JC and González-Llano, O and Herrera-Garza, JL. (2004) Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute leukemia eligible for conventional allografting: A prospective study Leukemia Lymphoma, 45, pp. 1191-1195.
12. Ruiz-Arguelles, A and Duque, RE and Orfao, A. (1998) Report on the first Latin American consensus conference for flow cytometric immunophenotyping of leukemia Cytometry (Commun Clin Cytometry), 34, pp. 39-42.
13. Ruiz-Argüelles, A and Rivadeneyra-Espinoza, L and Duque, RE and Orfao, A. (2005) Report of the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignancies Cytometry (Commun Clin Cytometry), 70B, pp. 39-44.
14. Kaplan, EL and Meier, P. (1958) Nonparametric estimations from incomplete observations J Am Stat Assoc, 53, pp. 457-463.
15. Stone, RM and ÖDonell, MR and Sekers, MA.(2004) Acute myeloid leukemia. In American Society of Hematology. (pp. 98-117). USA: Washington DC
16. Ruiz-Argüelles, GJ. (1997) Promyelocytic leukemia in Mexican mestizos Blood, 89, pp. 348-349.
17. Almaguer-Gaona, C and Cantú-Rodríguez, OG and Hernández-Garza, NE and Gómez-Almaguer, D. (1998) Leucemia aguda. Observaciones epidemiológicas en el Hospital Universitario de la Universidad Autónoma de Nuevo León Medicina Univ, 1, pp. 1517.
18. Ruiz-Argüelles, GJ and Gómez-Almaguer, D and Delgado-Lamas, JL and Gil-Rondero, C and Almaguer-Gaona, C and Apreza-Molina, MG. (1997) High frequency of acute promyelocytic leukemia in Mexican mestizos. A multicenter study Blood, 90(Suppl 1), pp. 233b. (Abstract)
19. Piedras, J and López-Karpovitch, X and Cárdenas, MR. (1997) Cellular immunophenotypes in 97 adults with acute leukemia Rev Invest Clin Méx, 49, pp. 457-464.
20. Ruiz-Argüelles, GJ and Morales-Toquero, A and Gómez-Rangel, JD and López-Martínez, B and Ruiz-Delgado, GJ and Reyes-Núntild;ez, V. (2005) Treatment of acute promyelocytic leukemia: A single institution experience Rev Invest Clin Méx, 57, pp. 415-419.
21. Nucifora, G and Rowley, JD. (1995) AML1 and the 8:21 translocation in acute and chronic myeloid leukemia Blood, 86, pp. 1-14.
22. Kita, K and Nakase, K and Miwa, H. (1992) Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21) (q22;q22) chromosomal abnormality: Frequent expression of immature B cell antigen CD19 together with stem cell antigen CD34 Blood, 80, pp. 470-477.
23. Marcucci, G and Mrozek, K and Ruppert, AS and Maharry, K and Kolitz, JE and Moore, JO and Mayer, RJ and Pettenati, MJ and Powell, BL and Edwards, CG and Sterling, LJ and Vardiman, JW and Schiffer, CA and Carroll, AJ and Larson, RA and Bloomfield, CD. (2005) Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): A Cancer and Leukemia Group B Study J Clin Oncol, 23, pp. 5705-5717.
24. Swansbury, GJ and Lawler, SD and Alimena, G. (1994) Long-term survival in acute myelogenous leukemia. A second follow up of the fourth international workshop on chromosomes in leukemia Cancer Genet Cytogenet, 73, pp. 1-7.
25. Lobato-Mendizábal, E and Ruiz-Argüelles, GJ and Ganci-Cerrud, G and Gómez-Almaguer, D and Lozano-de-la-Vega, A and Labardini-Mendez, J. (1991) Tratamiento a largo plazo y factores pronÓsticos en leucemia aguda mieloblástica del adulto. Experiencia del grupo INNSZ (Puebla-Monterrey-México) Rev Invest Clin Méx, 43, pp. 215-222.